Related references
Note: Only part of the references are listed.Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action
Yane Costa Chaves et al.
METABOLIC BRAIN DISEASE (2021)
Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors
Hui Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression
Clarissa Laczkovics et al.
NEUROPSYCHIATRIE (2021)
The kynurenine pathway: a finger in every pie
Jonathan Savitz
MOLECULAR PSYCHIATRY (2020)
Plasma mtDNA copy numbers are associated with GSTK1 expression and inflammation in type 2 diabetes
X. Deng et al.
DIABETIC MEDICINE (2020)
Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression
Jihao Xu et al.
JOURNAL OF DIABETES (2020)
Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling[S]
Claudia Manca et al.
JOURNAL OF LIPID RESEARCH (2020)
Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice
Jozimar Carlos Szczepanik et al.
NEUROCHEMICAL RESEARCH (2020)
Positive Association Between Serum Levels of High-Sensitivity C-Reactive Protein and Depression/Anxiety in Female, but Not Male, Patients With Type 2 Diabetes Mellitus
Qian-Qian Yang et al.
BIOLOGICAL RESEARCH FOR NURSING (2020)
Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?
Eduardo Duarte-Silva et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats
Bin Dong et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
Meilin Wei et al.
EBIOMEDICINE (2020)
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
Habib Yaribeygi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Neurobiological findings underlying depressive behavior in Parkinson's disease: A review
Ingrid Prata Mendonca et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
Andrzej Wrobel et al.
FRONTIERS IN PHARMACOLOGY (2020)
Evaluating blood-brain barrier permeability in a rat model of type 2 diabetes
Ju Qiao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Depression and cardiovascular disease events among patients with type 2 diabetes: A systematic review and meta-analysis with bias analysis
Kosuke Inoue et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Relationship between Serum Antioxidative Vitamin Concentrations and Type 2 Diabetes in Japanese Subjects
Chizumi Yamada et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2020)
Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system
Gregoire Chevalier et al.
NATURE COMMUNICATIONS (2020)
Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice
Yanming Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
A Probiotic Mixture Induces Anxiolytic- and Antidepressive-Like Effects in Fischer and Maternally Deprived Long Evans Rats
Valerie Dauge et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
Methylglyoxal and soluble RAGE in type 2 diabetes mellitus: Association with oxidative stress
Alisha Reyaz et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2020)
Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial
Asma Kazemi et al.
CLINICAL NUTRITION (2019)
Brain and behavioral correlates of insulin resistance in youth with depression and obesity
Manpreet K. Singh et al.
HORMONES AND BEHAVIOR (2019)
Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice
Zhanyang Yu et al.
MOLECULAR NEUROBIOLOGY (2019)
Coenzyme Q10 Alleviated Behavioral Dysfunction and Bioenergetic Function in an Animal Model of Depression
Sina Andalib et al.
NEUROCHEMICAL RESEARCH (2019)
Effects of cannabidiol in males and females in two different rat models of depression
Liat Shbiro et al.
PHYSIOLOGY & BEHAVIOR (2019)
Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans
Talisa Silzer et al.
PLOS ONE (2019)
Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation
Cheng-Fang Hsieh et al.
SCIENTIFIC REPORTS (2019)
Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
Natalia de M. Lyra e Silva et al.
FRONTIERS IN PSYCHIATRY (2019)
Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes
Jung Hwan Bae et al.
CELLS (2019)
Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
Shehan N. Randeria et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants
Ruth B. Grigolon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition
Fenqin Chen et al.
BMC PUBLIC HEALTH (2019)
Role of complement in diabetes
Ramzi A. Ajjan et al.
MOLECULAR IMMUNOLOGY (2019)
Plasma mitochondrial DNA is elevated in obese type 2 diabetes mellitus patients and correlates positively with insulin resistance
Larysa Yuzefovych et al.
PLOS ONE (2019)
Complement Component C3 Is Highly Expressed in Human Pancreatic Islets and Prevents β Cell Death via ATG16L1 Interaction and Autophagy Regulation
Ben C. King et al.
CELL METABOLISM (2019)
Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis
Aitak Farzi et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case-control study
Yeli Wang et al.
NUTRITION & METABOLISM (2019)
A single coadministration of subeffective doses of ascorbic acid and ketamine reverses the depressive-like behavior induced by chronic unpredictable stress in mice
Morgana Moretti et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies
Mohammad Khaledi et al.
ACTA DIABETOLOGICA (2019)
Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
Martina Zverova et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression
Bruce R. Stevens et al.
GUT (2018)
Biochemical and cellular properties of insulin receptor signalling
Rebecca A. Haeusler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression
D. Hen-Shoval et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior
Tina C. Franklin et al.
BIOLOGICAL PSYCHIATRY (2018)
The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus
Adel Abdel-Moneim et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Th17 cells in depression
Eleonore Beurel et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Depression and sterile inflammation: Essential role of danger associated molecular patterns
Tina C. Franklin et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes
Alena Viktorinova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries
C. E. Lloyd et al.
DIABETIC MEDICINE (2018)
The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy
Diling Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Endocannabinoid hydrolase and cannabinoid receptor 1 are involved in the regulation of hypothalamus-pituitary-adrenal axis in type 2 diabetes
Qihui Luo et al.
METABOLIC BRAIN DISEASE (2018)
Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression
Sara A. Khedr et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats
Helen de Morais et al.
NEUROSCIENCE LETTERS (2018)
Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study
Buranee Kanchanatawan et al.
NEUROTOXICITY RESEARCH (2018)
Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice
E. H. Taniguti et al.
PHYSIOLOGY & BEHAVIOR (2018)
The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression
Piotr Czarny et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
Amanda J. Sales et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes
Christian Herder et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
Jirapas Sripetchwandee et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Major depression model induced by repeated and intermittent lipopolysaccharide administration: Long-lasting behavioral, neuroimmune and neuroprogressive alterations
Francisca Taciana Sousa Rodrigues et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
Angelina Passaro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
The Bidirectional Relationship between Diabetes and Depression: A Literature Review
Abdallah Alzoubi et al.
KOREAN JOURNAL OF FAMILY MEDICINE (2018)
A case-control study: The association of serum paraoxonase 1 activity and concentration with the development of type 2 diabetes mellitus
J. Allen Crow et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study
Fleur E. P. van Dooren et al.
DEPRESSION AND ANXIETY (2017)
Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders
Monika Fleshner et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2017)
AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
Christina Alves Peixoto et al.
EXPERIMENTAL NEUROLOGY (2017)
Symptoms of Stress and Depression Effect Percentage of Body Fat and Insulin Resistance in Healthy Youth: LOOK Longitudinal Study
Lisa S. Olive et al.
HEALTH PSYCHOLOGY (2017)
Emerging role of Interleukins IL-23/IL-17 axis and biochemical markers in the pathogenesis of Type 2 Diabetes: Association with age and gender in human subjects
Naureen Fatima et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Chen-Pin Wang et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition
Marina Bogush et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Increased incidence of psychiatric disorders in immune-mediated inflammatory disease
Ruth Ann Marrie et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2017)
The role of the complement system in diabetic nephropathy
Allan Flyvbjerg
NATURE REVIEWS NEPHROLOGY (2017)
The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus
Ziqian Xu et al.
NEUROIMAGE (2017)
Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
Kyunghee Byun et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
Luiz Gustavo Piccoli de Melo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Inadequate Vitamin C Status in Prediabetes and Type 2 Diabetes Mellitus: Associations with Glycaemic Control, Obesity, and Smoking
Renee Wilson et al.
NUTRIENTS (2017)
Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications
Susana Rovira-Llopis et al.
REDOX BIOLOGY (2017)
Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats
Naveen Shivavedi et al.
BRAIN RESEARCH (2017)
Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice
Aurelijus Burokas et al.
BIOLOGICAL PSYCHIATRY (2017)
Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene
S. S. Krogh et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Plasma ferritin, C-reactive protein, and risk of incident type 2 diabetes in Singapore Chinese men and women
Ye-Li Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Concentrations of various tryptophan metabolites are higher in patients with diabetes mellitus than in healthy aged male adults
Kempei Matsuoka et al.
DIABETOLOGY INTERNATIONAL (2017)
Endocannabinoids - at the crossroads between the gut microbiota and host metabolism
Patrice D. Cani et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Age and sex differences in immune response following LPS treatment in mice
Kyle Chiman Cai et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
Wilma Helena Oliveira et al.
BRAIN RESEARCH (2016)
The Central Nervous System and the Gut Microbiome
Gil Sharon et al.
CELL (2016)
Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes?
Anastasiya Slyepchenko et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis
Chenxiao Liu et al.
CYTOKINE (2016)
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CBI receptors
Helen de Morais et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Jennifer L. Remus et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat
John R. Kelly et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Diet-microbiota interactions as moderators of human metabolism
Justin L. Sonnenburg et al.
NATURE (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Dalia K. Mostafa et al.
PSYCHOPHARMACOLOGY (2016)
Plasma C1q/TNF-Related Protein-3 (CTRP-3) and High-Mobility Group Box-1 (HMGB-1) Concentrations in Subjects with Prediabetes and Type 2 Diabetes
Huili Wei et al.
JOURNAL OF DIABETES RESEARCH (2016)
Regulation and function of AMPK in physiology and diseases
Sang-Min Jeon
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Expression of the kynurenine pathway enzymes in the pancreatic islet cells. Activation by cytokines and glucolipotoxicity
J. J. Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment
Katherine Semenkovich et al.
DRUGS (2015)
Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change
Adrian L. Lopresti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes
Gregory F. Oxenkrug
MOLECULAR NEUROBIOLOGY (2015)
Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors
Alexis S. Hill et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Insulin resistance in brain alters dopamine turnover and causes behavioral disorders
Andre Kleinridders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial
Ali Sahraian et al.
TRIALS (2015)
Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus
Yaozhi Hu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward
Melissa A. Stouffer et al.
NATURE COMMUNICATIONS (2015)
Hippocampal GSK3 beta as a Molecular Link Between Obesity and Depression
Ioannis K. Papazoglou et al.
MOLECULAR NEUROBIOLOGY (2015)
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
P. D. Cani et al.
DIABETES & METABOLISM (2014)
Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
Adrian L. Lopresti et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder
Chiara Cristina Bortolasci et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
Aurelijus Burokas et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes
B. Jayashree et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats
In Koo Hwang et al.
NEUROLOGICAL RESEARCH (2014)
Oxidative & nitrosative stress in depression: Why so much stress?
Steven Moylan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Advances in understanding the interrelations between leptin resistance and obesity
Haitao Pan et al.
PHYSIOLOGY & BEHAVIOR (2014)
Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
Kyoung-Sae Na et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Jeremie Boucher et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics
L. Geurts et al.
BENEFICIAL MICROBES (2014)
Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression
A. Karabatsiakis et al.
TRANSLATIONAL PSYCHIATRY (2014)
Diabetes drugs and neurological disorders: new views and therapeutic possibilities
Cesare Patrone et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Acute-Phase Serum Amyloid A Protein and Its Implication in the Development of Type 2 Diabetes in the KORA S4/F4 Study
Carola Marzi et al.
DIABETES CARE (2013)
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Eileen M. Moore et al.
DIABETES CARE (2013)
Time course of the effects of lipopolysaccharide on prepulse inhibition and brain nitrite content in mice
Charllyany Sabino Custodio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Curcumin and Diabetes: A Systematic Review
Dong-wei Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence
Souhel Najjar et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Insulin Resistance and Dysregulation of Tryptophan-Kynurenine and Kynurenine-Nicotinamide Adenine Dinucleotide Metabolic Pathways
Gregory Oxenkrug
MOLECULAR NEUROBIOLOGY (2013)
Association of CFH and CFB Gene Polymorphisms with Retinopathy in Type 2 Diabetic Patients
Jun Wang et al.
MEDIATORS OF INFLAMMATION (2013)
Systemic Immune Activation Leads to Neuroinflammation and Sickness Behavior in Mice
Steven Biesmans et al.
MEDIATORS OF INFLAMMATION (2013)
Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia
Lucie Geurts et al.
PLOS ONE (2013)
Selective Insulin and Leptin Resistance in Metabolic Disorders
A. Christine Koenner et al.
CELL METABOLISM (2012)
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
Brian Leonard et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity
Michael J. Stuart et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Depressive phenotypes evoked by experimental diabetes are reversed by insulin
Nancy Ho et al.
PHYSIOLOGY & BEHAVIOR (2012)
A Neural Circuitry Linking Insulin Resistance to Depressed Mood
John P. Ryan et al.
PSYCHOSOMATIC MEDICINE (2012)
Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats
Claudia A. Grillo et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Immune system to brain signaling: Neuropsychopharmacological implications
Lucile Capuron et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
Michael Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
Michael Maes
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat
Juan Hidalgo et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G. Muccioli et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Neurobehavioral deficits in db/db diabetic mice
Ajaykumar N. Sharma et al.
PHYSIOLOGY & BEHAVIOR (2010)
Low serum HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder
Soili M. Lehto et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program
Ronald T. Ackermann et al.
OBESITY (2009)
Stress and Depression: Preclinical Research and Clinical Implications
Alessandro Bartolomucci et al.
PLOS ONE (2009)
Imbalance between Pro- and Anti-inflammatory Cytokines, and between Th1 and Th2 Cytokines in Depressed Patients: The Effect of Electroacupuncture or Fluoxetine Treatment
C. Song et al.
PHARMACOPSYCHIATRY (2009)
Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease
J. K. Morris et al.
BRAIN RESEARCH (2008)
Cannabinoid receptor 1 (CNR1) gene:: Impact on antidepressant treatment response and emotion processing in Major Depression
Katharina Domschke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Lentivirus-mediated downregulation of hypothalamic insulin receptor expression
C. A. Grillo et al.
PHYSIOLOGY & BEHAVIOR (2007)
Cytokine imbalance in the pathophysiology of major depressive disorder
Yong-Ku Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Activation of c-jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis
Heather Klintworth et al.
TOXICOLOGICAL SCIENCES (2007)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
IL-1β-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes
JC O'Connor et al.
JOURNAL OF IMMUNOLOGY (2005)
Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses
O Chan et al.
ENDOCRINOLOGY (2005)
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
L Santarelli et al.
SCIENCE (2003)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
Share Paper
